Form D — Nula Therapeutics, Inc.
0002121301-26-000001 · filed Mar 18, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $7,399,003
- Reported amount sold
- $7,399,003
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Nula Therapeutics, Inc.
- CIK
- 2121301
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 961 Arlington Ave N
St. Petersburg, Florida 33705 - Phone
- 212-392-4735
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Shepard · Executive OfficerSt. Petersburg, Florida Find on LinkedIn ↗
-
Jarod Rutledge · DirectorSt. Petersburg, Florida Find on LinkedIn ↗
-
Nils Regge · DirectorSt. Petersburg, Florida Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗